Google too hard?
• A trans female (MTF) student-athlete being treated with testosterone suppression medication for Gender Identity Disorder or gender dysphoria and/or
Transsexualism, for the purposes of NCAA competition may continue to compete
on a men’s team but may not compete on a women’s team without changing it to a mixed team status until completing one calendar year of testosterone suppression treatment.
• Any transgender student-athlete who is not taking hormone treatment related to gender transition may participate in sex-separated sports activities in accordance with his or her assigned birth gender.
• A trans male (FTM) student-athlete who is not taking testosterone related
to gender transition may participate on a men’s or women’s team.
• A trans female (MTF) transgender student-athlete who is not taking hormone treatments related to gender transition may not compete on a women’s team. http://www.dartmouthsports.com/pdf9/2375985.pdf?DB_OEM_ID=11600
In other words, the doomsday scenario you describe cannot happen under NCAA rules.
So the NCAA has defined gender female purely on the basis of taking "testosterone suppression treatment." Do they give benchmarks?
Regarding the doomsday scenario. Look what this guy had to do to keep his job. People will go a long way to get in to a selective university and get it paid for. If that means saying "I identify as female" and taking estogen supplements to "prove it" they will.
Unless they have defined metrics of "testosterone suppression treatment" it will get messy when someone tries to game the system.Details Emerge in SAC Capital Sex Harassment Case
By Charles Gasparino
Wednesday, 10 Oct 2007 | 2:45 PM EThttp://www.cnbc.com/id/21224443
Sexual harassment cases are nothing new on Wall Street, but CNBC has uncovered new details of one of the most salacious cases to hit a big trading house in a long time.
The case involves a sexual harassment lawsuit filed by a Andrew Z. Tong, a former junior trader at SAC Capital, the powerful Greenwich, Conn., hedge fund, against one of SAC’s top producers, a trader named Ping Jiang.
A New York State judge has sealed the case and sent the lawsuit into arbitration, where both sides would battle it out in private. He even cancelled oral arguments that were scheduled for Thursday following an appeal by Tong’s lawyers, who want the case to remain in state court.
The judge said he sealed the details of Tong’s allegations contained in the lawsuit because it is not in the public interest to disclose the salacious nature of the complaints. CNBC has learned the suit includes the following allegations made by Tong against Jiang:
* After being hired at SAC, Tong alleges that Jiang came to him and told him he had a trading method in which his traders must not be too aggressive; that traders must be more effeminate and to do so, he directed Tong to begin taking female hormones.
* Tong says he then took the female hormones that he bought on the black market.
* Tong then alleges he suffered emotional and physical distress. The hormones, he says, caused him to begin wearing women's clothes. He also could not perform sexually with his wife, who wanted to have a baby.
* Tong says the sexual harassment included sexual relations between the two men.
Tong's attorney had no comment.
SAC Capital and Jiang vehemently denying the charges, saying in a statement that: “SAC conducted a thorough investigation and found these scurrilous accusations to be false. We will vigorously defend ourselves and are confident that these claims will be swiftly rejected in arbitration.”
Tong was terminated by SAC Capital in April 2006 after working there less than a year. SAC, according to people close to the firm, say he was fired for cause. Tong, according to others, claim he was forced out of the firm.